← All companies

PURE

PURE Bioscience, Inc.

PURE OTC Miscellaneous Chemical Products EDGAR ↗

$0.06

-0.01 -14.29%

Key statistics

from XBRL data in SEC filings

Market cap

$7.80M

Revenue (TTM)

$2.42M

Net income (TTM)

-$2.21M

EPS (TTM)

$-0.01

P/E ratio

—

Dividend yield

—

Free cash flow

-$2.05M

Cash

$983K

Total assets

$1.56M

Gross margin

58.8%

52-week range

$0.04 – $0.14

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-04-30 Jun 15, 2026 8-K Results of operations (earnings release) Jun 15, 2026 8-K Entered a material agreement; Unregistered sale of equity May 5, 2026 10-Q Quarter ended 2026-01-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 17, 2026 8-K Shareholder vote results Feb 20, 2026 10-Q Quarter ended 2025-10-31 Dec 15, 2025 8-K Results of operations (earnings release) Dec 15, 2025 8-K Director or officer change Nov 19, 2025 10-K Fiscal year ended 2025-07-31 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 10-Q Quarter ended 2025-04-30 Jun 16, 2025 8-K Results of operations (earnings release) Jun 16, 2025 10-Q Quarter ended 2025-01-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Shareholder vote results Jan 28, 2025 10-Q Quarter ended 2024-10-31 Dec 16, 2024 8-K Results of operations (earnings release) Dec 16, 2024 10-K Fiscal year ended 2024-07-31 Oct 29, 2024 8-K Results of operations (earnings release) Oct 29, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 20, 2024 8-K Amended charter or bylaws Aug 9, 2024 10-Q Quarter ended 2024-04-30 Jun 14, 2024 8-K Results of operations (earnings release) Jun 14, 2024 8-K Director or officer change May 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 27, 2024 10-Q Quarter ended 2024-01-31 Mar 18, 2024 8-K Results of operations (earnings release) Mar 18, 2024 8-K Shareholder vote results Feb 26, 2024 10-Q Quarter ended 2023-10-31 Dec 14, 2023 8-K Results of operations (earnings release) Dec 14, 2023 10-K Fiscal year ended 2023-07-31 Oct 30, 2023 8-K Results of operations (earnings release) Oct 30, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 10, 2023 10-Q Quarter ended 2023-04-30 Jun 14, 2023 8-K Results of operations (earnings release) Jun 14, 2023 8-K Director or officer change Mar 21, 2023 10-Q Quarter ended 2023-01-31 Mar 17, 2023 8-K Results of operations (earnings release) Mar 17, 2023 8-K Shareholder vote results Feb 10, 2023